Data & Metadata,
Journal Year:
2024,
Volume and Issue:
3
Published: Dec. 4, 2024
Polycystic
ovary
syndrome
(PCOS)
is
a
complex
endocrine
and
metabolic
condition
that
significantly
affects
the
fertility
of
women
reproductive
age.
The
aim
study
was
to
analyze
polycystic
its
impact
on
infertility
through
PRISMA
2020
literature
review.
A
systematic
search
conducted
in
PubMed
using
MeSH
terms
related
PCOS
infertility,
covering
publications
from
2018
2024.
Original
articles,
reviews,
relevant
meta-analyses
were
included,
while
duplicate
studies
or
those
with
insufficient
methodological
quality
excluded.
results
showed
hyperandrogenism,
insulin
resistance,
chronic
inflammation
are
key
mechanisms
affecting
ovulation
endometrial
quality,
contributing
infertility.
Lifestyle
modifications,
such
as
diet
exercise,
identified
first
line
treatment,
emerging
therapies
like
resveratrol,
probiotics,
traditional
Chinese
medicine
offer
promising
options.
Additionally,
relationships
between
comorbidities
thyroid
diseases
osteoporosis
observed,
expanding
systemic
impact.
Despite
advances
pathophysiological
understanding,
challenges
persist
due
lack
classification
genotypes
clinical
phenotypes.
It
concluded
management
should
be
comprehensive
personalized,
integrating
innovative
multidisciplinary
strategies
improve
patients'
life
outcomes.
This
provides
solid
foundation
guide
future
research
optimize
practice
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(3), P. 405 - 405
Published: Jan. 23, 2025
Introduction:
The
beneficial
effect
of
probiotics
on
the
improvement
carbohydrate
and
lipid
metabolism,
as
well
body
mass
index
(BMI),
has
been
demonstrated
in
various
patient
groups.
We
aimed
to
investigate
a
multi-strain
probiotic
hormonal
balance
women
with
PCOS.
Ethical
approval
was
obtained
from
Bioethical
Committee.
Methods:
study
designed
12-week,
randomized,
double-blind,
placebo-controlled
clinical
study.
SanProbi®
Barrier
capsules,
which
contain
unique
composition
nine
bacteria
strains
(Lactobacillus
Biffidobacterium),
were
used
mean
age
participants
28.42
±
5.62
years.
A
total
50
PCOS,
diagnosed
based
Rotterdam
ESHRE
criteria,
included
Among
them,
25
randomized
placebo
group,
group.
Results:
comparison
changes
individual
hormone
levels
between
groups
confirmed
statistically
significant
differences
for
TSH,
androstenedione,
SHBG,
BMI.
In
case
LH,
statistical
significance
difference
delta
change
group
use
one-tailed
test.
Conclusions:
Probiotic
supplementation
may
serve
an
alternative
supporting
treatment,
especially
phenotype
high
FAI
index.
therapy
is
also
effective
reducing
BMI
overweight
PCOS
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(7), P. 938 - 938
Published: March 24, 2024
Polycystic
ovary
syndrome
(PCOS)
is
a
multifaceted
and
heterogeneous
disorder,
linked
with
notable
reproductive,
metabolic,
psychological
outcomes.
During
adolescence,
key
components
of
PCOS
treatment
involve
weight
loss
achieved
through
lifestyle
dietary
interventions,
subsequently
pursued
by
pharmacological
or
surgical
therapies.
Nutritional
interventions
represent
the
first-line
therapeutic
approach
in
adolescents
affected
PCOS,
but
different
kinds
protocols
exist,
so
it
necessary
to
clarify
effectiveness
benefits
most
well-known
nutritional
approaches.
We
provided
comprehensive
review
current
literature
concerning
definition,
pathophysiology,
options,
highlighting
strategies,
particularly
those
related
high-fat
diets.
The
proposed
literature,
such
as
ketogenic
diet
(KD),
appear
provide
patients
terms
control
metabolic
parameters.
Among
types
KD
studies,
very
low-calorie
diets
(VLCKD),
can
be
considered
an
effective
intervention
for
short-term
PCOS.
It
rapidly
leads
alongside
improvements
body
composition
profile.
Even
though
extremely
advantageous,
long-term
adherence
limiting
factor.
Indeed,
this
regimen
could
become
unsustainable
due
important
restrictions
required
ketosis
development.
Thus,
combination
more
nutrient-rich
regimens,
Mediterranean
diet,
amplify
positive
effects
individuals
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(22), P. 3916 - 3916
Published: Nov. 16, 2024
Polycystic
ovary
syndrome
is
a
common
endocrine
disorder
in
women
of
reproductive
age
characterized
by
insulin
resistance
and
hormonal
imbalances.
Recent
research
suggests
that
probiotics
synbiotics
may
improve
these
parameters
modulating
the
gut
microbiota.
This
study
systematically
reviewed
randomized
clinical
trials
evaluating
impact
probiotic,
prebiotic,
synbiotic
supplementation
on
with
PCOS.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(14), P. 4243 - 4243
Published: July 20, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
and
polycystic
ovary
syndrome
(PCOS)
are
prevalent
conditions
that
have
been
correlated
with
infertility
through
overlapped
pathophysiological
mechanisms.
MASLD
is
associated
metabolic
considered
among
the
major
causes
of
chronic
disease,
while
PCOS,
which
characterized
by
ovulatory
dysfunction
hyperandrogenism,
one
leading
female
infertility.
The
links
between
PCOS
not
yet
fully
elucidated,
insulin
resistance,
hyperandrogenemia,
obesity,
dyslipidemia
being
key
pathways
contribute
to
lipid
accumulation,
inflammation,
fibrosis,
aggravating
dysfunction.
On
other
hand,
exacerbates
resistance
dysregulation
in
women
creating
a
vicious
cycle
progression.
Understanding
intricate
relationship
crucial
improving
clinical
management,
collaborative
efforts
different
medical
specialties
essential
optimize
fertility
health
outcomes
individuals
PCOS.
In
this
review,
we
summarize
complex
interplay
highlighting
importance
increasing
attention
prevention,
diagnosis,
treatment
both
entities.
NTU Journal of Pure Sciences,
Journal Year:
2025,
Volume and Issue:
3(4)
Published: Jan. 1, 2025
Abstract.
The
etiology
of
polycystic
ovary
syndrome
(PCOS)
is
complex
and
includes
both
endocrine
in
addition
to
immunological
abnormalities.
PCOS
a
condition
that
involves
chronic
low-grade
inflammation,
which
the
pathological
state
regulation
pro-inflammatory
factors
release
rate
dysfunctioning
endotheliocytes
accumulation
leukocytes.
In
PCOS,
particular,
immune
cells
regulatory
molecules
participate
significantly
maintain
metabolic
homeostasis
modulate
reactions.
People
with
may
have
hormonal
changes
such
as
low
levels
progesterone
because
it
usually
occurs
irregularly
or
stops
ovulated
turn
overstimulation
system
results
from
autoantibodies
production.
addition,
dysfunction
cytokines
imbalance
are
associated
insulin
resistance,
hyperandrogenism
obesity
PCOS.
also
causes
immunity
create
an
inflammatory
aura.
Autoimmune
diseases
patients
be
developed
due
imbalances.
There
been
studies
indicating
connection,
between
underlying
It
appears
grade
inflammation
strongly
can
contribute
loss
ovulation.
Additionally
there
seems
ovarian
cytokines,
disrupt
functions
lead
excessive
production
androgens
increase
resistance
through
various
mechanisms.
article
aims
shed
light
on
role
disturbance
disease,
including
its
emergence
development.
This
deeper
understanding
mechanism
help
finding
new
therapeutic
targets
reduce
severity
disease
poor
fertility
women
suffered
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 8, 2025
Polycystic
ovary
syndrome
(PCOS)
is
a
common
gynecological
condition
affecting
individuals
of
reproductive
age
and
linked
to
the
gut
microbiome.
This
study
aimed
identify
hotspots
research
trends
within
domain
microbiome
in
PCOS
through
bibliometric
analysis.
Utilizing
techniques,
we
examined
literature
on
from
Web
Science
Core
Collection
spanning
period
2012
2023.
Analytical
tools
such
as
CiteSpace,
VOSviewer,
Bibliometric
R
packages
were
employed
evaluate
various
metrics,
including
countries/regions,
institutions,
authors,
co-cited
authors'
H-index,
journals,
co-references,
keywords.
A
total
191
publications
identified
field
PCOS,
with
an
increase
annual
2018
People's
Republic
China
was
most
productive
country,
followed
by
United
States
America
(USA),
India.
Shanghai
Jiao
Tong
University,
Fudan
Beijing
University
Chinese
Medicine
top
three
institutions.
Thackray
VG
prolific
author,
holding
highest
while
Liu
received
number
citations.
The
journal
"Frontiers
Endocrinology"
published
articles
this
domain.
frequently
reference
authored
Qi
XY.
analysis
keyword
burst
detection
"bile
acids"
(2021-2023)
leading
frontier
keyword.
Additionally,
"gut
dysbiosis,"
"phenotypes,"
"adolescents,"
"metabolomics,"
"metabolites,"
"fecal
microbiota
transplantation,"
"IL-22"
have
emerged
primary
keywords
reflecting
recent
trends.
explores
how
influences
endocrine
metabolic
disorders
related
emphasizing
its
role
development
treatments
targeting
findings
serve
valuable
resource
for
researchers,
enabling
them
critical
emerging
areas
investigation
field.
Journal of Research in Medical Sciences,
Journal Year:
2025,
Volume and Issue:
30(1)
Published: Jan. 1, 2025
Background:
The
objective
of
this
study
was
to
compare
the
effects
early
time-restricted
eating
(eTRE)
and
eTRE
plus
probiotic
supplementation
daily
caloric
restriction
(DCR)
alone
in
terms
biomarkers
oxidative
stress
(OS),
antioxidant
capacity,
inflammation,
blood
pressure
(BP)
obese
women
with
polycystic
ovary
syndrome
(PCOS).
Materials
Methods:
research
conducted
as
a
randomized,
parallel,
placebo-controlled
clinical
trial
an
8-week
follow-up
period.
Participants
were
randomly
assigned
one
three
groups:
14:10
(
n
=
30),
placebo
or
DCR
30).
At
beginning
8
weeks
intervention,
systolic
(SBP)
diastolic
BP,
OS
parameters
evaluated.
Results:
A
total
90
participants
(mean
age,
30.49
years
mean
weight,
81.45
kg)
enrolled
trial.
After
we
observed
SBP
significantly
decreased
both
+
group
(−0.31
mmHg
[95%
confidence
interval
(CI):
−0.55,
−0.07])
(−0.24
CI:
−0.43,
0.04]),
no
significant
differences
between
groups.
Moreover,
C-reactive
protein
(CRP)
levels
reduced
all
groups
P
<
0.005).
Total
capacity
(TAC)
also
showed
notable
improvement
0.012)
0.032).
However,
there
regarding
OS,
TAC,
CRP
markers.
Conclusion:
It
not
found
that
probiotics
intervention
resulted
improving
inflammatory,
than
standard
diet
among
PCOS.
present
did
reveal
improvements
inflammatory
markers,
either
combined
compared
diagnosed
Trial
Register
no:
IRCT20121110011421N5.